(Press-News.org) PITTSBURGH, July 9, 2015 - Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health. Those with strong immune systems, however, might benefit from waiting until after the end of the six-month TB treatment before initiating anti-HIV therapy, they found.
In a study published in the current issue of Annals of Internal Medicine, the team recommended updating physician guidelines to take the findings into account.
Infection with HIV can promote progression and re-infection to active TB after initial exposure to Mycobacterium tuberculosis, the organism that causes TB, explained senior author Jean B. Nachega, M.D., Ph.D., M.P.H., associate professor of infectious diseases and microbiology and of epidemiology, Pitt Public Health. Treating HIV and TB simultaneously is challenging for many reasons, including the requirement for patients to take multiple pills several times daily for each infection, drug-drug interactions and overlapping side effects.
"Current World Health Organization guidelines recommend starting TB treatment first, followed by HIV treatment as soon as possible within two to eight weeks for patients who have moderately to severely compromised immune systems, but there was not conclusive evidence to guide treatment in other levels of immune suppression," Dr. Nachega said. "We aimed to investigate the optimal timing of HIV initiation in light of recent published randomized clinical trials on this topic."
The team systematically reviewed data from more than 4,500 people participating in eight randomized clinical trials of early initiation of HIV anti-retroviral therapy (ART) conducted in Asia, Africa and the United States. They found that survival rates were better among patients who started ART within two weeks of the initiation of TB treatment and who also had very low CD4 T-cell counts of less than 0.050 x 109cells/liter, as measured by a blood test which reflects severe immune system suppression due to HIV infection. Of note, early initiation also was associated with a two-fold increase in the frequency of a complication called TB-Immune Reconstitution Inflammatory Syndrome, which can be fatal in rare occasions. There was no evidence to support or refute a survival benefit for patients with CD4 counts between 0.050 and 0.220 x 109cells/liter.
"Our findings support guidelines recommending early initiation of ART in patients with a high degree of immune system compromise," Dr. Nachega said. "But delaying ART might be possible until the end of TB treatment with patients with CD4 counts greater than 0.220 x 109cells/liter, which could reduce the burden of taking two complex drug regimens at the same time."
However, Dr. Nachega noted that there is other emerging evidence showing the clinical and public health benefits associated with early initiation of HIV treatment, other than survival. Indeed, early treatment may be beneficial by decreasing comorbidities due to ongoing inflammation caused by HIV and decreasing HIV sexual transmission.
"Clinicians will need to weigh these benefits against the burden of co-administration of TB and HIV treatment on a case-by-case basis, but the overarching goal is likely to be a move toward treating all HIV-positive people as early as possible," said Dr. Nachega.
INFORMATION:
The team included researchers from the University of Pittsburgh; Warwick Medical School, United Kingdom; Liverpool School of Tropical Medicine, United Kingdom; Stellenbosch University, South Africa; South African Medical Research Council; University Medical Center Utrecht, The Netherlands; Johns Hopkins Bloomberg School of Public Health; and University College London, United Kingdom.
The research team was supported with funding from the Swedish Council for Working Life and Social Research; the National Institute for Allergy and Infectious Disease of the National Institutes of Health; the AIDS Clinical Trial Group; and Stellenbosch University Clinical Trial Unit; the Medical Education Partnership Initiative through the U.S. President Emergency Plan for AIDS Relief; the European Developing Countries Clinical Trial Partnership Senior Fellowship Award; the Wellcome Trust Southern Africa Consortium for Research Excellence; the European Commission Seventh Framework Programme (Rapid Identification of Respiratory Tract Infections Project); and the South African Medical Research Council.
About the University of Pittsburgh Graduate School of Public Health
The University of Pittsburgh Graduate School of Public Health, founded in 1948 and now one of the top-ranked schools of public health in the United States, conducts research on public health and medical care that improves the lives of millions of people around the world. Pitt Public Health is a leader in devising new methods to prevent and treat cardiovascular diseases, HIV/AIDS, cancer and other important public health problems. For more information about Pitt Public Health, visit the school's Web site at http://www.publichealth.pitt.edu.
http://www.upmc.com/media
Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM@upmc.edu
Contact: Anita Srikameswaran
Phone: 412-578-9193
E-mail: SrikamAV@upmc.edu
In Borneo, some insectivorous bats have developed a rather intriguing relationship with carnivorous pitcher plants. The plants offer the bats a relatively cool place to roost, free of parasites and competition from other bats. In return, the bats keep the plants well fertilized with their droppings. Now, researchers reporting in the Cell Press journal Current Biology on July 9 show that the plants rely on special structures to reflect the bats' ultrasonic calls back to them. That adaptation of the plants makes it easier for bats to find their plant partners in the cluttered ...
A new technique that uses light to activate chemotherapy drugs in specific cells shows promise as a way to improve the effectiveness of cancer therapies while preventing severe side effects, according to a study published July 9 in Cell. The so-called photopharmacology approach could be used to treat a broad range of tumors with unprecedented precision simply by making existing cancer drugs sensitive to light--an approach that requires less time and effort compared with traditional drug discovery programs.
"We hope that our compounds will one day be used in medicine to ...
CAMBRIDGE, MA -- The "friendly" bacteria inside our digestive systems are being given an upgrade, which may one day allow them to be programmed to detect and ultimately treat diseases such as colon cancer and immune disorders.
In a paper published today in the journal Cell Systems, researchers at MIT unveil a series of sensors, memory switches, and circuits that can be encoded in the common human gut bacterium Bacteroides thetaiotaomicron.
These basic computing elements will allow the bacteria to sense, memorize, and respond to signals in the gut, with future applications ...
While human activities have caused extinctions across the globe, your favourite beach or diving site may actually be home to as many, or more, species then it was a few decades ago.
That's the conclusion of a synthesis of 50 years of marine biodiversity data conducted by University of British Columbia (UBC) researchers.
But there is a catch. Like other studies of its kind, the synthesis relies on species population time series from sites that haven't been subject to intense human development.
"Much as you'd expect, our study shows human impacts like pollution and ...
A study to examine recessively inherited genome-wide DNA sequences has for the first time discovered a potential link with Britain's biggest killer - Coronary Artery Disease (CAD).
The research led by a team from the University of Leicester was the first time that recessively inherited DNA sequences in the whole genome called Runs of homozygosity (ROHs) were examined for a connection to the disease.
The study appears in the American Journal of Human Genetics.
CAD is a terminal clinical manifestation of cardiovascular disease and is the leading cause of death worldwide ...
Danish researchers are the first in the world to have used our genes to investigate the impact of coffee on the body. The new study shows that coffee neither increases nor decreases the risk of lifestyle diseases.
We love coffee - and we drink a lot of it. New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that coffee neither increases nor decreases the risk of developing lifestyle diseases such as obesity and diabetes. The researchers have based their study on genes, as our genes play a role in how much coffee we drink in the course ...
DENVER (July 9, 2015) - A new study from the University of Colorado Denver finds that male exotic dancers, or strippers, remain committed to stripping because it enhances their self-concept.
The study by Maren Scull, an instructor of Sociology in the CU Denver College of Liberal Arts and Sciences, was published online this month in Deviant Behavior, the only scientific journal that specifically addresses behaviors that violate social norms. Scull's research focuses on how exotic dancing influences the way male strippers view themselves.
"Because stripping is a stigmatizing ...
This news release is available in French.
Since the treatment has become available, HIV is often described as "undetectable" and the risk of transmission has been drastically reduced. However, the epidemic is still quite present in the lives of many gay and bisexual men... and in public spaces. This often overlooked dimension of the disease has been brought to light by Gabriel Girard of the University of Montreal's Public Health Research Institute (IRSPUM) - HIV is still alive in the city, especially in the Village, Montreal's gay district. "Urban traces are significant ...
WEST LAFAYETTE, Ind. -- A key set of immune cells that protect the body from infection would be lost without directions provided by vitamin A, according to a recent study.
A team of researchers from Purdue University found retinoic acid, a metabolite that comes from digested vitamin A, is necessary for two of the three types of innate immune cells that reside in the intestine to find their proper place.
"It is known that vitamin A deficiencies lead to increased susceptibility to disease and low concentrations of immune cells in the mucosal barrier that lines the intestines," ...
MADISON, Wis. -- A study authored by two University of Wisconsin-Madison graduate students indicates that while playing video games can improve mood, violent games may increase aggressive outcomes.
The study, authored by James Alex Bonus and Alanna Peebles, graduate students in Communication Arts, and Karyn Riddle, assistant professor in the School of Journalism and Mass Communication, was published in June in the journal Computers in Human Behavior. The researchers looked at how video games may be used to manage emotions -- specifically, whether playing the games can ...
